These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29265087)

  • 1. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma].
    Deriugina AV; Shumilova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
    Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV
    Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EFFECT OF CITOFLAVIN ON THE PARAMETERS OF LIPID PEROXIDATION IN BLOOD PLASMA OF RATS UNDER COLD STRESS CONDITIONS.].
    Dorovskikh VA; Li ON; Simonova NV; Shtarberg MA
    Eksp Klin Farmakol; 2016; 79(7):29-34. PubMed ID: 29782743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
    Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotective effect of cytoflavin in closed craniocerebral trauma].
    Bul'on VV; Zarubina IV; Kovalenko AL; Alekseeva LE; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(6):56-8. PubMed ID: 14743715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [STRESS-PROTECTIVE EFFECT OF CYTOFLAVIN ON CHRONIC CEREBRAL ISCHEMIA IN RATS.].
    Krylov VN; Deryugina AV; Antipenko EA
    Eksp Klin Farmakol; 2016; 79(9):29-32. PubMed ID: 29787669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effect of cytoflavin and its components in mice with acute alloxan intoxication].
    Volchegorskiĭ IA; Rassokhina LM; Ermakova SG; Miroshnichenko IIu
    Eksp Klin Farmakol; 2013; 76(4):26-31. PubMed ID: 23762986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Muratov FK; Shermukhamedova FK; Batocyrenov BV; Haritonova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):44-47. PubMed ID: 28139625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenetic correction of metabolic disturbances in chronic liver affections].
    Romantsov MG; Petrov AIu; Aleksandrova LN; Sukhanov DS; Kovalenko AL
    Antibiot Khimioter; 2012; 57(11-12):33-41. PubMed ID: 23700935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Using cytoflavin for correcting x-ray contrasting agent-induced nephropathy].
    Karpishchenko SN; Zheregelia SN; Glushkov SI
    Eksp Klin Farmakol; 2010 Oct; 73(10):40-2. PubMed ID: 21254514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV; Scuderi A; Antignani PL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):28-35. PubMed ID: 28805757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy].
    Pochepen' ON
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin].
    Kartashova EA; Romantsov MG; Sarvilina IV
    Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of cytoflavin during compression injury of the spinal cord.
    Bul'on VV; Kuznetsova NN; Selina EN; Kovalenko AL; Alekseeva LE; Sapronov NS
    Bull Exp Biol Med; 2005 Apr; 139(4):394-6. PubMed ID: 16027862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives of treatment of patients with ischemic stroke: the place and the role of cytoflavin].
    Trofimova SA; Balunov OA; Dubinina EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):49-53. PubMed ID: 20559274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoflavin in polychemotherapy of breast cancer].
    Kashuro VA; Glushkov SI; Zheregelia SN
    Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
    Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
    Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of cytoflavin in the treatment of burnout syndrome].
    Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.